BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1308 related articles for article (PubMed ID: 22445098)

  • 1. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
    Montezano AC; Touyz RM
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
    Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting reactive oxygen species in hypertension.
    Cifuentes ME; Pagano PJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):179-86. PubMed ID: 16481886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.
    Montezano AC; Touyz RM
    Antioxid Redox Signal; 2014 Jan; 20(1):164-82. PubMed ID: 23600794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is oxidative stress a therapeutic target in cardiovascular disease?
    Münzel T; Gori T; Bruno RM; Taddei S
    Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension.
    Hirooka Y
    Hypertens Res; 2011 Apr; 34(4):407-12. PubMed ID: 21346766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species and glucocorticoid-induced hypertension.
    Ong SL; Zhang Y; Whitworth JA
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):477-82. PubMed ID: 18307745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mycophenolate more than just an immunosuppressant?--An overview.
    Iyer A; Brown L
    Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.
    Szasz T; Thakali K; Fink GD; Watts SW
    Exp Biol Med (Maywood); 2007 Jan; 232(1):27-37. PubMed ID: 17202583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and vascular remodelling.
    Fortuño A; San José G; Moreno MU; Díez J; Zalba G
    Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies.
    Montezano AC; Dulak-Lis M; Tsiropoulou S; Harvey A; Briones AM; Touyz RM
    Can J Cardiol; 2015 May; 31(5):631-41. PubMed ID: 25936489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.